Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
2008 Mar 27
At concentrations between 20 and 60 μg/mL
4SC-202 was used at 10µM final concentration in various in vitro assays
The subcutaneous tumor growth of both T24 and HeLa cell xenografts treated with PAI-039 is markedly reduced compared with untreated controls
3)19-11-13-20(14-12-19)29(24(31)21-10-8-16-32-21)22(18-9-7-15-27-17-18)23(30)28-26(4
Toceranib Catalog No.:M10886-10 2008 Mar 27Toceranib, also known as PHA 291639 and SU 11654, is a receptor tyrosine kinase inhibitor and is used in the treatment of canine mast cell tumor also called mastocytoma. Toceranib phosphate was approved for dog. Toceranib is likely to act mostly through inhibition of the kit tyrosine kinase, though it may also have an anti angiogenic effect. Product information CAS Number: 356068 94 5 Molecular Weight: 396. 46 Formula: C22H25FN4O2 Chemical Name: 5
US$ 1125.00
US$ 2275.00
US$ 1875.00
US$ 88500.00
US$ 1225.00
US$ 1249.50
US$ 1225.00
US$ 2375.00